CTGCT
  • en
    • si
  • About us
    • About CTGCT
    • Partners
    • CTGCT Days 2025
    • Publications
  • Job Openings
  • Products and Services
  • Learning Box
  • POSTS
    • Events
    • Articles
    • News
    • All posts
  • Get in touch

Regulation

  • Events
  • Researchers
  • Cell therapy
  • Gen Therapy
  • Clinic study
  • Marketaccess
  • Regulation
  • CTGCT
  • Rodrigo Ortiz
5 November 2025 Event Date: 27 October 2025 do: 29 October 2025 •

CTGCT Takeaways from the World Orphan Drug Congress Europe 2025

CTGCT attended the World Orphan Drug Congress (WODC) Europe 2025 in Amsterdam from the 27th to the 29th of October, an event dedicated to strategies and partnerships in the orphan drug industry. There were ...

1000018186
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Marketaccess
  • Regulation
  • CTGCT
  • Gregor Cuzak
10 October 2025

Academic developers for affordable medicines

CTGCT (Centre for the Technologies of Gene and Cell Therapy, at National institute of Chemistry, Ljubljana) has joined the statement to preserve the Hospital Exemption in the revised EU pharmaceutical legislation. The Joint Statement, ...

  • Articles
  • Clinicians
  • Pacients
  • Clinic study
  • Regulation
  • CTGCT
  • NIC
  • Gregor Cuzak
16 July 2025

CTIS public portal – a great tool for finding and exploring clinical trials in Europe

The Clinical Trials Information System (CTIS) public portal is a new European tool that allows anyone to access information about clinical trials taking place in the European Union (EU) and European Economic Area (EEA). ...

  • Events
  • Clinicians
  • Researchers
  • ATMPs
  • Regulation
  • Research
  • Rodrigo Ortiz
15 April 2025

ADVANCE 5-day Summer School on Cell and Gene Therapies

The next ADVANCE school on ATMP from Faculty of Pharmacy will happen here in Ljubljana. We think is a great FREE opportunity to learn more about ATMPs. Learn more in the official page of ...

Summer school
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Manufacturing Process
  • Regulation
  • CTGCT
  • UMCUtrecht
  • Rodrigo Ortiz
5 March 2025

Navigating Viral Vector Production for Gene Therapy

This week we had the opportunity to listen to Ganesh Ramesh, a PhD candidate at the Viral Vector Production Center for Translation Immunology of UMC Utrecht, under the supervision of Dr. Zsolt Sebestyen. Here ...

Ctgct Scientific Talk March 2025
  • Articles
  • Clinicians
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Manufacturing Process
  • Pre Clinical
  • Regulation
  • UCL
  • Rodrigo Ortiz
4 November 2024

Transforming Advanced Therapy Manufacturing: The Braintree Innovation Centre

case study on the Braintree Manufacturing Innovation Centre (Braintree MIC), recently licensed by the MHRA. This state-of-the-art facility is revolutionizing the field of advanced therapy medicinal products (ATMPs) by providing cutting-edge infrastructure and expertise ...

Braintree Mic
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • Investment
  • Raziskave
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • NIC
  • UCL
  • UMCUtrecht
  • Rodrigo Ortiz
25 October 2024 Event Date: 16 October 2024 do: 19 October 2024 •

Review of CTGCT Conference 2024

From the 16th of October 2024 to the 18th the Kemijski Inštitut hosted the 1st CTGCT Conference

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • GLP
  • GMP
  • Clinic study
  • Drug Discovery
  • Economics
  • Investment
  • Laboratory
  • Marketaccess
  • Pre Clinical
  • Regulation
  • Charite Berlin
  • CTGCT
  • NIC
  • UCL
  • UMCUtrecht
  • Gregor Cuzak
2 October 2024 Event Date: 18 October 2024 −

Program Announcement CTGCT Conference, 18th Oct 2024

Translational Medicine Ecosystem Ljubljana, Slovenia, Friday 18th October 2024, Location: Kemijski inštitut online transmission of event: webex teleconferencing link   8:30 Registration 9:00 Welcome Addresses Gregor Anderluh, National Institute of Chemistry Mojca Benčina, CTGCT ...

  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Regulation
  • CTGCT
  • NIC
  • Rodrigo Ortiz
20 September 2024

Bridging Gaps: ERN ITHACA and SATB2 Europe Visit the Center for Technologies of Gene and Cell Therapy

The CTGCT hosted representatives from ERN ITHACA and SATB2 Europe to discuss collaborative efforts in rare disease research and treatment. The meeting focused on developing innovative therapies and strengthening connections between researchers, clinicians, and ...

Ern Ithaca Visit
  • Events
  • Clinicians
  • Pacients
  • Researchers
  • ATMPs
  • Cell therapy
  • Gen Therapy
  • Business Model
  • Drug Discovery
  • Economics
  • Investment
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
12 September 2024 Event Date: 6 September 2024 • 09:00 do: 6 September 2024 •

European Commission Hosts Sixth Regional HTA Event in Budapest

The European Commission recently held its sixth regional event in Budapest, focusing on the upcoming Health Technology Assessment (HTA) regulation. Set to launch in January 2025, this new framework aims to streamline the evaluation ...

Hta 20230511 Banner 0
  • Events
  • Clinicians
  • Researchers
  • Cell therapy
  • Gen Therapy
  • GMP
  • Clinic study
  • Marketaccess
  • Regulation
  • Research
  • Charite Berlin
  • CTGCT
  • NIC
  • UMCUtrecht
  • Gregor Cuzak
1 July 2024

Panel Discussion on ATMP Regulation

The CTGCT organised its first Panel Discussion on 29 May entitled: ATMP Regulation. The main takeaway from the very successful session was that the strong potential of the Slovenian ecosystem requires the will to ...

  • Articles
  • Clinicians
  • Pacients
  • Researchers
  • Drug Discovery
  • Marketaccess
  • Regulation
  • Research
  • CTGCT
  • Gregor Cuzak
27 June 2024

Bespoke Gene Therapy Consortium – cooperation for rare disease therapies

At the Bespoke Gene Therapy Consortium (BGTC, website), a consortium for the treatment of rare monogenetic diseases, they aim to treat neglected diseases with a very small number of patients with a focus solely ...

Posts pagination

1 2

Logo Foot

Center for the Technologies of Gene and Cell Therapies (CTGCT) is an infrastructure center  within the National Institute of Chemistry, Slovenia

Contact

  • +386 1 4760 335
  • info@ctgct.si
  • Hajdrihova 19, 1001 Ljubljana

Privacy policy

  • Cookies

Follow us

X Twitter Brands SolidX-twitter

LinkedIn

Bluesky Brands Solid Bluesky

Funding

 

Eu Logo

Ukri Logo

Ministry Logo

 

Project: 101059842 – CTGCT – HORIZON-WIDERA-2022

Co-funded by the European Union, this project has received funding from Horizon Europe (grant agreement No. 101059842) and UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee (grant number 10069462). Views and opinions expressed are of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency (REA). Neither the European Commission nor the granting authority can be held responsible for them


CTGCT © 2025
Website production: Kreativna tovarna